Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14433)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2014 (publication date) through Jun 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations. World J Gastroenterol 2014; 20(28): 9330-9337 [PMID: 25071327 DOI: 10.3748/wjg.v20.i28.9330] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i28/9330.htm |
| Number | Citing Articles |
| 1 |
E.P.S. Conceição, E.G. Moura, P.N. Soares, X.X. Ai, M.S. Figueiredo, E. Oliveira, P.C. Lisboa. High calcium diet improves the liver oxidative stress and microsteatosis in adult obese rats that were overfed during lactation. Food and Chemical Toxicology 2016; 92: 245 doi: 10.1016/j.fct.2016.04.015
|
| 2 |
Wilbert S Aronow. Nonalcoholic Fatty Liver Disease is Associated With Coronary Artery Disease and Subclinical Atherosclerosis. Future Cardiology 2016; 12(4): 393 doi: 10.2217/fca-2016-0033
|
| 3 |
Zobair M. Younossi, Linda Henry. Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease. PharmacoEconomics 2015; 33(12): 1245 doi: 10.1007/s40273-015-0316-5
|
| 4 |
A. J. Krentz, K. Fujioka, M. Hompesch. Evolution of pharmacological obesity treatments: focus on adverse side‐effect profiles. Diabetes, Obesity and Metabolism 2016; 18(6): 558 doi: 10.1111/dom.12657
|
| 5 |
Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng. Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Cureus 2024; doi: 10.7759/cureus.71451
|
| 6 |
Xing Wang, Shiyu Lin, Shinan Gan, Yeqing Gu, Ying Yang, Qing Zhang, Li Liu, Ge Meng, Zhanxin Yao, Dong Zheng, Hongmei Wu, Shunming Zhang, Yawen Wang, Tingjing Zhang, Shaomei Sun, Qiyu Jia, Kun Song, Xiao-Hui Wu, Yuntang Wu, Kaijun Niu. Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study. European Journal of Clinical Nutrition 2021; 75(12): 1801 doi: 10.1038/s41430-021-00891-9
|
| 7 |
Caitlyn Tan, Kai En Chan, Cheng Han Ng, Michael Tseng, Nicholas Syn, Ansel Shao Pin Tang, Yip Han Chin, Wen Hui Lim, Darren Jun Hao Tan, Nicholas Chew, Elden Yen Hng Ong, Teng Kiat Koh, Jieling Xiao, Douglas Chee, Arun Valsan, Mohammad Shadab Siddiqui, Daniel Huang, Mazen Noureddin, Karn Wijarnpreecha, Mark D. Muthiah. DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals. Journal of Clinical Medicine 2022; 11(20): 6205 doi: 10.3390/jcm11206205
|
| 8 |
Gehan H. Heeba, Mohamed A. Morsy. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. Environmental Toxicology and Pharmacology 2015; 40(3): 907 doi: 10.1016/j.etap.2015.10.003
|
| 9 |
Mohammadreza Gholamrezapour, Raziyeh Taghizadeh Ghavamabadi, Mohammad Mohsen Taghavi, Samereh Dehghani Soltani, Ahmad Shabanizadeh, Reza Vazirinejad, Zahra Taghipour. Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells. Journal of Molecular Histology 2025; 56(1) doi: 10.1007/s10735-024-10313-2
|
| 10 |
Dimitrios S Karagiannakis, George Markakis, Dimitra Lakiotaki, Evangelos Cholongitas, Jiannis Vlachogiannakos, George Papatheodoridis. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2022; 34(9): 961 doi: 10.1097/MEG.0000000000002412
|
| 11 |
Li Zeng, Fangwei Zhong, Zhiliang Chen, Gengxi Li, Qi Zhu. Polygonatum sibiricum polysaccharides protect against obesity and non-alcoholic fatty liver disease in rats fed a high-fat diet. Food Science and Human Wellness 2022; 11(4): 1045 doi: 10.1016/j.fshw.2022.03.031
|
| 12 |
Goh Eun Chung, Sohee Oh, Dong-Won Ahn, Su Hwan Kim, Yong Jin Jung, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Bong Jeong. Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30833-3
|
| 13 |
Kuldeepak Sharma, Irena Zajc, Lovro Žiberna. Dietary vitamin D equilibrium in serum ameliorates direct bilirubin associated diabetes mellitus. Chemico-Biological Interactions 2021; 337: 109399 doi: 10.1016/j.cbi.2021.109399
|
| 14 |
Manasi Das, Deepak Kumar, Consuelo Sauceda, Alexis Oberg, Lesley G. Ellies, Liping Zeng, Lily J. Jih, Isabel G. Newton, Nicholas J. G. Webster. Time-Restricted Feeding Attenuates Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma in Obese Male Mice. Cancers 2024; 16(8): 1513 doi: 10.3390/cancers16081513
|
| 15 |
M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, P. Tsarkova, C. Marinova, D. Popov, L. Mateva, T. Tankova. Metabolic determinants of NAFLD in adults with type 1 diabetes. Diabetes Research and Clinical Practice 2022; 186: 109819 doi: 10.1016/j.diabres.2022.109819
|
| 16 |
Shira Azulai, Ronit Grinbaum, Nahum Beglaibter, Shai Meron Eldar, Moshe Rubin, Rachel Ben-Haroush Schyr, Orly Romano-Zelekha, Danny Ben-Zvi. Sleeve Gastrectomy Is Associated with a Greater Reduction in Plasma Liver Enzymes Than Bypass Surgeries—A Registry-Based Two-Year Follow-Up Analysis. Journal of Clinical Medicine 2021; 10(5): 1144 doi: 10.3390/jcm10051144
|
| 17 |
Haider Ghazanfar, Sameer D Kandhi, Iqra Nawaz, Nismat Javed, Minu C Abraham, Mohamed Farag, Jaydeep Mahasamudram, Vishwa B Patel, Faryal Altaf, Harish Patel. Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article. Cureus 2021; doi: 10.7759/cureus.15141
|
| 18 |
Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina. Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines. Life 2024; 14(1): 93 doi: 10.3390/life14010093
|
| 19 |
Derya ARĞUN, Pelin BASİM, Betül BÖRKÜ UYSAL, Ferit ARGUN. Association of circulating preptin with non-alcoholic fatty liver disease: A case-control study. Journal of Surgery and Medicine 2021; 5(6): 628 doi: 10.28982/josam.859388
|
| 20 |
Fengjin Li, Genli Liu, Piliang Xue, Zhen Ren, Peifang Dai, Wenying Niu, Mu Xin, Mi Mi Ko. YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5511019
|
| 21 |
Haisheng Chai, Sicheng Gao, Yaoyao Dai, Jinhua Dai, Gang Zhao, Junfeng Zhu. Association between nutritional status indices and non-alcoholic fatty liver disease in older adults: insights from the National Health and Nutrition Examination Survey 2017–2018. British Journal of Nutrition 2024; 132(9): 1123 doi: 10.1017/S0007114524001442
|
| 22 |
Batoul Ghaddar, Laura Gence, Bryan Veeren, Matthieu Bringart, Jean-Loup Bascands, Olivier Meilhac, Nicolas Diotel. Aqueous Extract of Psiloxylon mauritianum, Rich in Gallic Acid, Prevents Obesity and Associated Deleterious Effects in Zebrafish. Antioxidants 2022; 11(7): 1309 doi: 10.3390/antiox11071309
|
| 23 |
Jinyuan Wang, Biyun Liao, Changsheng Wang, Ou Zhong, Xiaocan Lei, Yuli Yang, Sonia Medina. Effects of Antioxidant Supplementation on Metabolic Disorders in Obese Patients from Randomized Clinical Controls: A Meta‐Analysis and Systematic Review. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/7255413
|
| 24 |
Adrian Rotaru, Remus Stafie, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Horia Minea, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Carol Stanciu, Anca Trifan. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025; 15(2): 288 doi: 10.3390/life15020288
|
| 25 |
F. Meng, L. Pian, Q. Wang, J. Chen, Y. Liu, J. Zhao. Ultrasound-guided attenuation parameter: a liver fat quantification technique for forecasting the progression of metabolic dysfunction-associated steatotic liver disease in overweight/obese patients. Clinical Radiology 2025; 84: 106854 doi: 10.1016/j.crad.2025.106854
|
| 26 |
Bahar Arasteh, Sina Hamzehzadeh, Kia Seyed Toutounchi, Zeinab Nikniaz, Leila Amini, Leila Alizadeh. Association of ultrasound signs of sarcopenia with serum ferritin levels and hepatic indices like NFS and FIB-4 in NAFLD patients. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03773-7
|
| 27 |
Kirthika Venkatesan, Nisha Nigil Haroon. Management of Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 547 doi: 10.1016/j.ecl.2023.02.002
|
| 28 |
Fei‐Qi Xu, Qing‐Yun Xu, Zhang‐Ji Zhu, Lei Jin, Tai‐Wei Ye, Cheng‐Fei Du, Zhen‐Yu Gao, Xiao‐Kun Huang, Zhe Zhang, Li‐Ming Jin, Wei‐Feng Yao. Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: A Mendelian randomization study. International Journal of Cancer 2024; 154(3): 530 doi: 10.1002/ijc.34751
|
| 29 |
Carlota Laura Iñiguez Ubiaga, Carlos García Porrúa, José Antonio Pinto Tasende, Lorena Paula Iñiguez Ubiaga, Amalia Sánchez-Andrade Fernandez. Índice de fibrosis hepática 4: uso en la evaluación de la enfermedad del hígado graso no alcohólico en pacientes con artritis psoriásica. Reumatología Clínica 2023; 19(9): 495 doi: 10.1016/j.reuma.2023.04.001
|
| 30 |
Tessa Brand, Inge Christina Lamberta van den Munckhof, Marinette van der Graaf, Kiki Schraa, Helena Maria Dekker, Leonardus Antonius Bernardus Joosten, Mihai Gheorghe Netea, Niels Peter Riksen, Jacqueline de Graaf, Joseph Henricus Wilhelmus Rutten. Superficial vs Deep Subcutaneous Adipose Tissue: Sex-Specific Associations With Hepatic Steatosis and Metabolic Traits. The Journal of Clinical Endocrinology & Metabolism 2021; 106(10): e3881 doi: 10.1210/clinem/dgab426
|
| 31 |
Ziying Zhang, Changwei Liu, Wenwen Fang, Quanquan Tang, Li Zhan, Yu Shi, Mengge Tang, Zhonghua Liu, Sheng Zhang, Ailing Liu. Research progress on the lipid-lowering and weight loss effects of tea and the mechanism of its functional components. The Journal of Nutritional Biochemistry 2023; 112: 109210 doi: 10.1016/j.jnutbio.2022.109210
|
| 32 |
Jiayue Cao, T. Zhu, M. Anpo, A. Sharifi. Effects of Natural Products on Nonalcoholic Fatty Liver Disease through Nrf2 Epigenetic Regulation. E3S Web of Conferences 2021; 271: 04029 doi: 10.1051/e3sconf/202127104029
|
| 33 |
Ahmad Bairqdar, Dinara Ivanoshchuk, Elena Shakhtshneider. Functionally Significant Variants in Genes Associated with Abdominal Obesity: A Review. Journal of Personalized Medicine 2023; 13(3): 460 doi: 10.3390/jpm13030460
|
| 34 |
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022; 158(11): 550 doi: 10.1016/j.medcle.2022.05.009
|
| 35 |
Nailah Adams Morancie, Catherine Ellis, Alyssa Heinrich, Justin Lee. Chronic Illness Care. 2023; : 29 doi: 10.1007/978-3-031-29171-5_3
|
| 36 |
Song Lu, Qiyang Xie, Maobin Kuang, Chong Hu, Xinghui Li, Huijian Yang, Guotai Sheng, Guobo Xie, Yang Zou. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04047-0
|
| 37 |
Jessica Wisocky, Sonali Paul. The rising incidence of nonalcoholic fatty liver disease. The Nurse Practitioner 2017; 42(7): 14 doi: 10.1097/01.NPR.0000520420.17084.bb
|
| 38 |
Hangkai Huang, Zhening Liu, Jiarong Xie, Chengfu Xu. Association between night shift work and NAFLD: a prospective analysis of 281,280 UK Biobank participants. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-16204-7
|
| 39 |
Lucas M. Marks, Thomas Jensen, Timothy R. DeGrado. Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis. Metabolism and Target Organ Damage 2024; 4(3) doi: 10.20517/mtod.2024.44
|
| 40 |
Luisa Lampignano, Rossella Donghia, Annamaria Sila, Ilaria Bortone, Rossella Tatoli, Sara De Nucci, Fabio Castellana, Roberta Zupo, Sarah Tirelli, Viviana Giannoccaro, Vito Guerra, Francesco Panza, Madia Lozupone, Mauro Mastronardi, Giovanni De Pergola, Gianluigi Giannelli, Rodolfo Sardone. Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study. Nutrients 2022; 14(2): 258 doi: 10.3390/nu14020258
|
| 41 |
Mohammad Ariya, Farbod Koohpayeh, Alireza Ghaemi, Saeed Osati, Sayed Hossain Davoodi, Jalaledin Mirzay Razzaz, Gholamali Javedan, Elham Ehrampoush, Reza Homayounfar, Gianfranco D. Alpini. Assessment of the association between body composition and risk of non-alcoholic fatty liver. PLOS ONE 2021; 16(4): e0249223 doi: 10.1371/journal.pone.0249223
|
| 42 |
Itzel Y. Rojas, Benjamin J. Moyer, Carol S. Ringelberg, Owen M. Wilkins, Darcy B. Pooler, Dylan B. Ness, Shodeinde Coker, Tor D. Tosteson, Lionel D. Lewis, Mary D. Chamberlin, Craig R. Tomlinson. Kynurenine‐Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia. Obesity 2021; 29(2): 337 doi: 10.1002/oby.23065
|
| 43 |
Asmita Chopra, Michael Devries, Rachel Mullins, Roberta Redfern, Kerri Ann Simo. Laparoscopic Liver Resection: A Tool to Improve Outcomes in Obese Patients Requiring Liver Resection. Open Journal of Gastroenterology 2022; 12(12): 347 doi: 10.4236/ojgas.2022.1212036
|
| 44 |
Lei Miao, Giovanni Targher, Christopher D. Byrne, Ying-Ying Cao, Ming-Hua Zheng. Current status and future trends of the global burden of MASLD. Trends in Endocrinology & Metabolism 2024; 35(8): 697 doi: 10.1016/j.tem.2024.02.007
|
| 45 |
Qing Liu, Zepeng Zhang, Peng Ji, Jiaqi Liu, Boxue Chen, Mingyao E, Hongyu Qi, Tong Hou, Qingxia Huang, Lu Ding, Chen Guo, Daqing Zhao, Wenzhi Yang, Zeyu Wang, Xiangyan Li. Ginseng polysaccharide components attenuate obesity and liver lipid accumulation by regulating fecal microbiota and hepatic lysine degradation. International Journal of Biological Macromolecules 2024; 269: 131872 doi: 10.1016/j.ijbiomac.2024.131872
|
| 46 |
Song Lu, Maobin Kuang, Jiajun Qiu, Wenjuan Li, Min Zhang, Guotai Sheng, Yang Zou, Xiaoping Peng. Lipids as the link between central obesity and diabetes: perspectives from mediation analysis. BMC Endocrine Disorders 2024; 24(1) doi: 10.1186/s12902-024-01764-5
|
| 47 |
Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand. Obese Animals as Models for Numerous Diseases: Advantages and Applications. Medicina 2021; 57(5): 399 doi: 10.3390/medicina57050399
|
| 48 |
Xiaoqiong Zeng. Correlation analysis of BMI with ovulation effect and clinical pregnancy rate in patients with polycystic ovary syndrome. American Journal of Translational Research 2024; 16(8): 4174 doi: 10.62347/KYES1276
|
| 49 |
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24): 15489 doi: 10.3390/ijms232415489
|
| 50 |
Yazhi Wang, Hui Chen. Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetes. Hormones 2025; 24(1): 109 doi: 10.1007/s42000-024-00593-4
|
| 51 |
Hamda M. Aboujassoum, Vidya Mohamed-Ali, David Abraham, Lucie H. Clapp, Hamda A. Al-Naemi. Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats. Nutrients 2023; 16(1): 115 doi: 10.3390/nu16010115
|
| 52 |
Beatriz Gonçalves dos Santos, Rosiane Aparecida Miranda, Lucas Paulo Jacinto Saavedra, Flávio Andrade Francisco, Maiara Vanusa Guedes Ribeiro, Anna Rebeka Oliveira Ferreira, Marcos Divino Ferreira-Junior, Keilah Valéria Naves Cavalcante, Carlos Henrique Xavier, Egberto Gaspar de Moura, Patrícia Cristina Lisboa, Ariel Penha Carvalho da Mota, Gustavo Rodrigues Pedrino, James Andrew Armitage, Paulo Cezar de Freitas Mathias, Kesia Palma-Rigo, Rodrigo Mello Gomes. Puberty as a DOHaD programming window: high-fat diet induces long-term hepatic dysfunction in male rats. Journal of Developmental Origins of Health and Disease 2023; 14(5): 614 doi: 10.1017/S2040174423000272
|
| 53 |
Zhigang Yang, Youngjin Wi, Young‐Min Yoon, Peter Verwilst, Joo Hee Jang, Tae Woo Kim, Chulhun Kang, Jong Seung Kim. BODIPY/Nile‐Red‐Based Efficient FRET Pair: Selective Assay of Endoplasmic Reticulum Membrane Fluidity. Chemistry – An Asian Journal 2016; 11(4): 527 doi: 10.1002/asia.201501060
|
| 54 |
Chunbo Li, Mengchun Li, Zhenwei Wang. There is a linear negative correlation between lipoprotein(a) and non-alcoholic fatty liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93518-z
|
| 55 |
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
|
| 56 |
Lei Pan, Lixuan Wang, Huijuan Ma, Fan Ding. Relevance of combined influence of nutritional and inflammatory status on non‐alcoholic fatty liver disease and advanced fibrosis: A mediation analysis of lipid biomarkers. Journal of Gastroenterology and Hepatology 2024; 39(12): 2853 doi: 10.1111/jgh.16760
|
| 57 |
Yasunari Kato, Masami Sakoh, Toshiharu Nagai, Akihiko Yoshida, Hideaki Ishida, Nao Inoue, Teruyoshi Yanagita, Koji Nagao. Ozonated Olive Oil Intake Attenuates Hepatic Steatosis in Obese <i>db</i>/<i>db</i> Mice. Journal of Oleo Science 2024; 73(2): 231 doi: 10.5650/jos.ess23193
|
| 58 |
Hyo-Geun Lee, You-Jin Jeon, Min-Cheol Kang. Fucoidan from Sargassum thunbergii obtained via step gradient ethanol precipitation indicate potential anti-obesity and anti-hepatic steatosis in vitro 3T3-L1 and HepG2 cells and in vivo high-fat diet-induced obesity mice. Food and Chemical Toxicology 2023; 174: 113686 doi: 10.1016/j.fct.2023.113686
|
| 59 |
H. Pakyurek, M.R. Aykota, O. Kilic-Erkek, M. Ozban, H. Senol, M. Bor-Kucukatay. Investigation of time-dependent alterations in adipokine levels and endoplasmic reticulum stress markers in obese patients with laparoscopic sleeve gastrectomy. Life Sciences 2023; 330: 121987 doi: 10.1016/j.lfs.2023.121987
|
| 60 |
Zengliang Jiang, Liuqing He, Diyin Li, Laibao Zhuo, Lingjun Chen, Rui-Qi Shi, Jianhua Luo, Yuhui Feng, Yuhui Liang, Danyang Li, Xiao Congmei, Yuanqing Fu, Yu-ming Chen, Ju-Sheng Zheng, Liang Tao. Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control. Nature Metabolism 2025; 7(4): 808 doi: 10.1038/s42255-025-01246-5
|
| 61 |
Wentong Zhang, Jun Wang, Luanfeng Wang, Renjie Shi, Chuanqi Chu, Zhiling Shi, Pujie Liu, Yitong Li, Xuebo Liu, Zhigang Liu. Alternate-day fasting prevents non-alcoholic fatty liver disease and working memory impairment in diet-induced obese mice. The Journal of Nutritional Biochemistry 2022; 110: 109146 doi: 10.1016/j.jnutbio.2022.109146
|
| 62 |
Geng Wang, Qingbo Wang, Jie Bai, Gang Li, Kaixiong Tao, Guobin Wang, Zefeng Xia, Susanne Kaser. RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment. PLOS ONE 2020; 15(12): e0243640 doi: 10.1371/journal.pone.0243640
|
| 63 |
Hirokazu Taniguchi, Miho Ueda, Fumika Sano, Yukiko Kobayashi, Takatomo Shima. Dietary characteristics associated with the risk of non‐alcoholic fatty liver disease and metabolic dysfunction‐associated steatotic liver disease in non‐obese Japanese participants: A cross‐sectional study. JGH Open 2024; 8(5) doi: 10.1002/jgh3.13082
|
| 64 |
Jing Huang, Tian Gao, Huinan Zhang, Xing Wang. Association of obesity profiles and metabolic health status with liver injury among US adult population in NHANES 1999–2016. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43028-7
|
| 65 |
Andrei Baiceanu, Pierre Mesdom, Marie Lagouge, Fabienne Foufelle. Endoplasmic reticulum proteostasis in hepatic steatosis. Nature Reviews Endocrinology 2016; 12(12): 710 doi: 10.1038/nrendo.2016.124
|
| 66 |
Ju-Seop Kang, Hyun-Jin Kim, So-Jung Lim, Sang-Won Lee, Inyoung Hwang. A Comprehensive Guide to Nonalcoholic Fatty Liver Disease [Working Title]. 2025; doi: 10.5772/intechopen.1010672
|
| 67 |
Yu Zhu, Hu Yang, Shaoxian Liang, Honghua Zhang, Yufeng Mo, Songxian Rao, Yaozong Zhang, Zhuang Zhang, Weiqiang Wang, Wanshui Yang. Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(21): 4462 doi: 10.3390/nu14214462
|
| 68 |
Carlota Iñiguez Ubiaga, Carlos García Porrúa, José Antonio Pinto Tasende, Lorena Paula Iñiguez Ubiaga, Amalia Sánchez-Andrade Fernandez. Liver fibrosis 4 score: Use in the evaluation of non-alcoholic fatty liver disease in patients with psoriatic arthritis. Reumatología Clínica (English Edition) 2023; 19(9): 495 doi: 10.1016/j.reumae.2023.04.004
|
| 69 |
Min-Kyung Lee, Hye-Jeong Park, Won Seon Jeon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee. Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. Cardiovascular Diabetology 2015; 14(1) doi: 10.1186/s12933-015-0253-9
|
| 70 |
Daniel Toman, Ilker Sengul, Anton Pelikán, Demet Sengul, Petr Vavra, Petr Ihnat, Jan Roman, Cuneyt Kayaalp. A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?. Revista da Associação Médica Brasileira 2022; 68(6): 871 doi: 10.1590/1806-9282.20220268
|
| 71 |
Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review. Endocrine and Metabolic Science 2021; 3: 100089 doi: 10.1016/j.endmts.2021.100089
|
| 72 |
Kento Imajo, Yasushi Honda, Masato Yoneda, Satoru Saito, Atsushi Nakajima. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. Journal of Medical Ultrasonics 2020; 47(4): 535 doi: 10.1007/s10396-020-01059-x
|
| 73 |
Hangxiu Che, Yaqun Wang, Jinhui Lao, Yixin Deng, Chirui Xu, Hanxiao Yin, Zheng Tang, Yonghong Huang, Hong Xu. Role of purinergic signalling in obesity-associated end-organ damage: focus on the effects of natural plant extracts. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1181948
|
| 74 |
Ritesh Chimoriya, Milan K Piya, David Simmons, Golo Ahlenstiel, Vincent Ho. The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 10(1): 95 doi: 10.3390/jcm10010095
|
| 75 |
David Uihwan Lee, Greg Hongyuan Fan, Ryan Richard Ahern, Raffi Karagozian. The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011–2017 hospital data. European Journal of Gastroenterology & Hepatology 2021; 32(2): 269 doi: 10.1097/MEG.0000000000001991
|
| 76 |
Yujin Shin, Mijeong Lee, Dongju Lee, Joonseong Jang, Soon Shik Shin, Michung Yoon. Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice. International Journal of Molecular Sciences 2021; 22(7): 3675 doi: 10.3390/ijms22073675
|
| 77 |
Chisa Nishida, Hiroyuki Honda, Yuki Otsuka, Hideharu Hagiya, Yasuhiro Nakano, Kohei Oguni, Kazuki Tokumasu, Yasue Sakurada, Mikako Obika, Fumio Otsuka. Impact of Lifestyle Changes on Body Weight Gain During Nationwide Lockdown Due to COVID-19 Pandemic. Journal of Clinical Medicine 2025; 14(7): 2242 doi: 10.3390/jcm14072242
|
| 78 |
Thitiya Lukkunaprasit, Amarit Tansawet, Suparee Boonmanunt, Abhasnee Sobhonslidsuk, Gareth J. McKay, John Attia, Ammarin Thakkinstian. An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33023-3
|
| 79 |
Dulmini Wathsala Rathnayake, Piumika Sooriyaarachchi, Madunil Anuk Niriella, Dileepa Ediriweera, Jennifer Perera. Herbal treatments for non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Advances in Integrative Medicine 2024; doi: 10.1016/j.aimed.2024.08.016
|
| 80 |
Dayana Cabrera, Jorge Moncayo-Rizzo, Karen Cevallos, Geovanny Alvarado-Villa. Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador. Geriatrics 2023; 8(2): 42 doi: 10.3390/geriatrics8020042
|
| 81 |
Jiongshan Zhang, Yue Li, Gemin Xiao, Yongwei Li, Heping Xie, Yan Chen. Fructooligosaccharides enhance the therapeutic effect of xiao-zhi-fang on non-alcoholic fatty liver disease via regulating intestinal flora. Liver Research 2021; 5(4): 217 doi: 10.1016/j.livres.2021.06.003
|
| 82 |
Bo Zhu, Hao Wu, Kathryn S. Li, Shahram Eisa-Beygi, Bandana Singh, Diane R. Bielenberg, Wendong Huang, Hong Chen. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis. Vascular Pharmacology 2024; 154: 107249 doi: 10.1016/j.vph.2023.107249
|
| 83 |
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2022; 41(10): 2364 doi: 10.1016/j.clnu.2022.07.003
|
| 84 |
W Shan, L Gao, W Zeng, Y Hu, G Wang, M Li, J Zhou, X Ma, X Tian, J Yao. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death & Disease 2015; 6(7): e1833 doi: 10.1038/cddis.2015.196
|
| 85 |
Maria Lúcia Bonfleur, Patrícia Cristine Borck, Rosane Aparecida Ribeiro, Luiz Carlos Caetano, Gabriela Moreira Soares, Everardo Magalhães Carneiro, Sandra Lucinei Balbo. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. Life Sciences 2015; 135: 15 doi: 10.1016/j.lfs.2015.05.019
|
| 86 |
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2023; 42(6): 987 doi: 10.1016/j.clnu.2023.03.021
|
| 87 |
Federica Sileo, Alessandro Leone, Ramona De Amicis, Andrea Foppiani, Laila Vignati, Francesca Menichetti, Giorgia Pozzi, Simona Bertoli, Alberto Battezzati. Thyroid Stimulating Hormone Levels Are Related to Fatty Liver Indices Independently of Free Thyroxine: A Cross-Sectional Study. Journal of Clinical Medicine 2025; 14(7): 2401 doi: 10.3390/jcm14072401
|
| 88 |
Fatemeh Yazdani, Behzad Shareghi, Sadegh Farhadian, Lida Momeni. Structural insights into the binding behavior of flavonoids naringenin with Human Serum Albumin. Journal of Molecular Liquids 2022; 349: 118431 doi: 10.1016/j.molliq.2021.118431
|
| 89 |
Haiwen Li, Ahmed Reza Rafie, Anwar Hamama, Rafat A. Siddiqui. Immature ginger reduces triglyceride accumulation by downregulating Acyl CoA carboxylase and phosphoenolpyruvate carboxykinase-1 genes in 3T3-L1 adipocytes. Food & Nutrition Research 2023; 67 doi: 10.29219/fnr.v67.9126
|
| 90 |
Erika R. Bjørnå, Martine T. Engelsen, Hashem B. El-Serag, Eivind Ness-Jensen. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study. Scandinavian Journal of Gastroenterology 2023; 58(5): 505 doi: 10.1080/00365521.2022.2139633
|
| 91 |
Mohammad Ali Sardar, Sadegh Abbasian, Hamid Moghavemi, Mina Karabi. HIIT may ameliorate inter-organ crosstalk between liver and hypothalamus of HFD-induced MAFLD rats; A two-phase study to investigate the effect of exercise intensity as a stressor. Brain Research 2025; 1856: 149591 doi: 10.1016/j.brainres.2025.149591
|
| 92 |
Roberta Zupo, Fabio Castellana, Francesco Panza, Marco Castellana, Luisa Lampignano, Raffaele Ivan Cincione, Vincenzo Triggiani, Gianluigi Giannelli, Vittorio Dibello, Rodolfo Sardone, Giovanni De Pergola. Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes. Journal of Clinical Medicine 2021; 10(8): 1695 doi: 10.3390/jcm10081695
|
| 93 |
Linxiao Gao, Jianping Gong, Guochao Zhong, Yajun Qin. Day napping and metabolic-associated fatty liver disease: A systematic review and meta-analysis of observational studies. Medicine 2024; 103(44): e40362 doi: 10.1097/MD.0000000000040362
|
| 94 |
Ming Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Xi Wang. Intermittent Fasting—A Healthy Dietary Pattern for Diabetic Nephropathy. Nutrients 2022; 14(19): 3995 doi: 10.3390/nu14193995
|
| 95 |
Bao Zhong, Feng-Lin Li, Jia-Yao Zhao, Yao Fu, Cheng Peng. Sporoderm-broken spore powder of Ganoderma lucidum ameliorate obesity and inflammation process in high-fat diet-induced obese mice. Food & Nutrition Research 2022; 66 doi: 10.29219/fnr.v66.8745
|
| 96 |
I-Ting Lin, Mei-Yueh Lee, Chih-Wen Wang, Da-Wei Wu, Szu-Chia Chen. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. International Journal of Environmental Research and Public Health 2021; 18(3): 857 doi: 10.3390/ijerph18030857
|
| 97 |
Song Wen, Shuren Xu, Thiquynhnga Nguyen, Min Gong, Huafang Yan, Ligang Zhou. Metabolic Effects on Body Components After a Three-Month Physical Intervention in Overweight Medical Staff. Cureus 2021; doi: 10.7759/cureus.19027
|
| 98 |
Na Li, Lin Yin, Jiamin Shang, Meidai Liang, Zhaoyu Liu, Haiguang Yang, Guifen Qiang, Guanhua Du, Xiuying Yang. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway. Biomedicine & Pharmacotherapy 2023; 165: 115113 doi: 10.1016/j.biopha.2023.115113
|
| 99 |
Chia-Wen Lo, Jyun-Lin Lee, Wei-Ting Tsai, Chin-Shiu Huang, Ya-Chen Yang, Chong-Kuei Lii, Haw-Wen Chen. Benzyl isothiocyanate ameliorates hepatic insulin resistance in mice with high-fat diet-induced nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry 2025; : 109981 doi: 10.1016/j.jnutbio.2025.109981
|
| 100 |
Дарья Александровна Скуратовская, Александра Андреевна Комар, Мария Александровна Вульф, ву Кванг Хунг, Павел Анатольевич Затолокин, Лариса Сергеевна Литвинова. STUDY OF INFLAMMATORY PROCESSES IN LIVER BIOPTATES IN PATIENTS WITH TYPE 2 DIABETES. Наука. Исследования. Практика: сборник избранных статей по материалам Международной научной конференции (Санкт-Петербург, Декабрь 2020) 2021; : 15 doi: 10.37539/SRP294.2020.30.35.014
|
| 101 |
Aleksandra Kołota, Dominika Głąbska. Dietary Intake of Milk Thistle Seeds as a Source of Silymarin and Its Influence on the Lipid Parameters in Nonalcoholic Fatty Liver Disease Patients. Applied Sciences 2021; 11(13): 5836 doi: 10.3390/app11135836
|
| 102 |
Yasmine Sebti, Aurore Hebras, Benoit Pourcet, Bart Staels, Hélène Duez. From Obesity to Diabetes. Handbook of Experimental Pharmacology 2022; 274: 29 doi: 10.1007/164_2021_579
|
| 103 |
Rui-Bing Feng, Chun-Lin Fan, Qing Liu, Zhong Liu, Wei Zhang, Yao-Lan Li, Wei Tang, Ying Wang, Man-Mei Li, Wen-Cai Ye. Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model. Chinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0054-9
|
| 104 |
N. A. Mazerkina, A. N. Savateev, S. K. Gorelyshev, S. A. Mariashev, S. A. Beregovskaya, A. N. Konovalov. Hepatopulmonary syndrome: a rare manifestation of cirrhosis in patient with diencephalic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma. Problems of Endocrinology 2021; 67(5): 58 doi: 10.14341/probl12723
|
| 105 |
Lubna Kamani, Moneeba Siddiqui, Adeel Rahat. Frequency of insulin resistance among non-diabetic patients with non-alcoholic fatty liver disease using HOMA-IR: an experience of a tertiary care hospital in Karachi, Pakistan. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03790-6
|
| 106 |
Cheyenne Braojos, Miguel Rebollo-Hernanz, Vanesa Benitez, Silvia Cañas, Yolanda Aguilera, Silvia M. Arribas, Maria A. Martin-Cabrejas. Simulated Gastrointestinal Digestion Influences the In Vitro Hypolipidemic Properties of Coffee Pulp, a Potential Ingredient for the Prevention of Non-Alcoholic Fatty Liver Disease. First International Electronic Conference on Nutrients, Microbiota and Chronic Disease 2020; : 19 doi: 10.3390/IECN2020-06997
|
| 107 |
Ioanna Aggeletopoulou, Maria Kalafateli, Efthymios P. Tsounis, Christos Triantos. Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(16): 12864 doi: 10.3390/ijms241612864
|
| 108 |
Guy Bower, Thanos Athanasiou, Alberto M. Isla, Leanne Harling, Jia V. Li, Elaine Holmes, Evangelos Efthimiou, Ara Darzi, Hutan Ashrafian. Bariatric surgery and nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(7): 755 doi: 10.1097/MEG.0000000000000375
|
| 109 |
Hong-Ye Peng, Shao-Jie Duan, Liang Pan, Mi-Yuan Wang, Jia-Liang Chen, Yi-Chong Wang, Shu-Kun Yao. Development and validation of machine learning models for nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2023; 22(6): 615 doi: 10.1016/j.hbpd.2023.03.009
|
| 110 |
Xin Li, Keke Guo, Tao Li, Shaoxin Ma, Shanshan An, Shanshan Wang, Jiao Di, Siyu He, Jihua Fu. 5-HT 2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats. Obesity Research & Clinical Practice 2018; 12(1): 16 doi: 10.1016/j.orcp.2016.03.015
|
| 111 |
Pooja Yadav, Khushi Quadri, Renu Kadian, Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam. New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products. iLIVER 2024; 3(4): 100131 doi: 10.1016/j.iliver.2024.100131
|
| 112 |
Simone A. Melander, Anna Katri, Morten A. Karsdal, Kim Henriksen. Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin. European Journal of Pharmacology 2023; 938: 175397 doi: 10.1016/j.ejphar.2022.175397
|
| 113 |
Shariful Islam Nayan, Faizul Islam Chowdhury, Noushin Akter, Md Mizanur Rahman, Saima Selim, Nadia Saffoon, Ferdous Khan, Nusrat Subhan, Maqsud Hossain, K. Shahin Ahmed, Hemayet Hossain, Md Areeful Haque, Md Ashraful Alam, Vanessa Souza-Mello. Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats. PLOS ONE 2021; 16(4): e0250261 doi: 10.1371/journal.pone.0250261
|
| 114 |
Tengrui Cao, Chao Tong, Qiang Li, Yumei Han, Aheyeerke Halengbieke, Xuetong Ni, Bo Gao, Deqiang Zheng, Xinghua Yang. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(5): 1245 doi: 10.1016/j.numecd.2024.01.001
|
| 115 |
G. P. Mendes, P. H. S. Silva, P. V. P. Gonçalves, E. M. M. Lima, A. R. C. Barreto-Vianna. Quantification of the liver structure of zebrafish (Danio rerio) submitted to different diets and physical exercise. Brazilian Journal of Biology 2023; 83 doi: 10.1590/1519-6984.276465
|
| 116 |
Mlindeli Gamede, Lindokuhle Mabuza, Phikelelani Ngubane, Andile Khathi. Plant-derived oleanolic acid ameliorates markers of subclinical inflammation and innate immunity activation in diet-induced pre-diabetic rats. Therapeutic Advances in Endocrinology and Metabolism 2020; 11 doi: 10.1177/2042018820935771
|
| 117 |
Mina Radmehr, Reza Homayounfar, Abolghasem Djazayery. The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study. Frontiers in Nutrition 2025; 11 doi: 10.3389/fnut.2024.1494497
|
| 118 |
Arch G. Mainous, Benjamin J. Rooks, James F. Medley, Samuel B. Dickmann. Body composition among adults at a healthy body mass index and association with undetected non-alcoholic fatty liver. International Journal of Obesity 2022; 46(7): 1403 doi: 10.1038/s41366-022-01124-0
|
| 119 |
Soyeon Shin, Jaeyoung Kim, Ju Yeon Lee, Jun Kim, Chang-Myung Oh. Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Obesity & Metabolic Syndrome 2023; 32(4): 289 doi: 10.7570/jomes23054
|
| 120 |
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterology Journal 2022; 10(7): 663 doi: 10.1002/ueg2.12280
|
| 121 |
Tannaz Jamialahmadi, Mehdi Azizmohammad Looha, Sara Jangjoo, Nima Emami, Mohammed Altigani Abdalla, Mohammadreza Ganjali, Sepideh Salehabadi, Sercan Karav, Thozhukat Sathyapalan, Ali H. Eid, Ali Jangjoo, Amirhossein Sahebkar. Predictive performance of noninvasive factors for liver fibrosis in severe obesity: a screening based on machine learning models. Journal of Diabetes & Metabolic Disorders 2025; 24(1) doi: 10.1007/s40200-025-01564-1
|
| 122 |
Giovanni De Pergola, Fabio Castellana, Roberta Zupo, Sara De Nucci, Francesco Panza, Marco Castellana, Luisa Lampignano, Martina Di Chito, Vincenzo Triggiani, Rodolfo Sardone, Gianluigi Giannelli. A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03583-3
|
| 123 |
Jing Ren, Xiaoyu Wang, Christine Yee, Mark D. Gorrell, Susan V. McLennan, Stephen M. Twigg. Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. Molecules 2022; 27(3): 727 doi: 10.3390/molecules27030727
|
| 124 |
Nicole Power Guerra, Luisa Müller, Kristin Pilz, Annika Glatzel, Daniel Jenderny, Deborah Janowitz, Brigitte Vollmar, Angela Kuhla. Dietary-Induced Low-Grade Inflammation in the Liver. Biomedicines 2020; 8(12): 587 doi: 10.3390/biomedicines8120587
|
| 125 |
Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, James G. Terry, Mark A. Pereira. Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study. Obesity Science & Practice 2024; 10(2) doi: 10.1002/osp4.751
|
| 126 |
Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand. In Vitro Mimicking of Obesity-Induced Biochemical Environment to Study Obesity Impacts on Cells and Tissues. Diseases 2022; 10(4): 76 doi: 10.3390/diseases10040076
|
| 127 |
Mak-Soon Lee, Cheamin Kim, Hyunmi Ko, Yangha Kim. Inhibitory effect of water-soluble mulberry leaf extract on hepatic lipid accumulation in high-fat diet-fed rats via modulation of hepatic microRNA-221/222 expression and inflammation. Journal of Nutrition and Health 2022; 55(2): 227 doi: 10.4163/jnh.2022.55.2.227
|
| 128 |
Lianggui Xiao, Mingming Li, Yang Xiao, Lin Yu, Yu Li, Zhiwang Zhang, Guo Zhang, Yixing Li, Lei Zhou, Yunxiao Liang. Echinocystic acid prevents obesity and fatty liver via interacting withFABP1. Phytotherapy Research 2023; 37(8): 3617 doi: 10.1002/ptr.7839
|
| 129 |
Anouk Charlot, Joffrey Zoll. Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic Review. Diabetology 2022; 3(2): 292 doi: 10.3390/diabetology3020020
|
| 130 |
Hatice Merve Bayram, Fuzail Mohammed Majoo, Arda Ozturkcan. Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies. Clinical Nutrition ESPEN 2021; 44: 1 doi: 10.1016/j.clnesp.2021.06.026
|
| 131 |
Cristina Rodriguez-Diaz, Bernard Taminiau, Alberto García-García, Alejandro Cueto, Mercedes Robles-Díaz, Aida Ortega-Alonso, Flores Martín-Reyes, Georges Daube, Judith Sanabria-Cabrera, Miguel Jimenez-Perez, M. Isabel Lucena, Raúl J. Andrade, Eduardo García-Fuentes, Miren García-Cortes. Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury. Pharmacological Research 2022; 182: 106348 doi: 10.1016/j.phrs.2022.106348
|
| 132 |
Xinjuan Huang, Ruoling Yu, Xinyun Tan, Manjie Guo, Yuanqin Xia, Huihui Zou, Xuelian Liu, Chunxiang Qin. Comparison of NAFLD, MAFLD, and MASLD Prevalence and Clinical Characteristics in Asia Adults. Journal of Clinical and Experimental Hepatology 2025; 15(1): 102420 doi: 10.1016/j.jceh.2024.102420
|
| 133 |
Petri Niinisalo, Olli T. Raitakari, Mika Kähönen, Mikko Hurme, Terho Lehtimäki, Costan Magnussen, Jorma Viikari, Markus Juonala, Risto Kaaja. IDO activity forecasts obesity in males and premenopausal females in a 10-year follow-up study:The Cardiovascular Risk in Young Finns Study. Atherosclerosis 2021; 336: 32 doi: 10.1016/j.atherosclerosis.2021.09.018
|
| 134 |
Santiago Otero Parra, Juliana Pineda Ortega, Jorge Sebastián Ramírez Valbuena, William Alberto Otero Regino. Impacto de la cirugía bariátrica en la incidencia de diferentes cánceres. Revisión narrativa. Revista colombiana de Gastroenterología 2023; 38(3): 321 doi: 10.22516/25007440.951
|
| 135 |
Viswanathan Saraswathi, Narendra Kumar, Thiyagarajan Gopal, Saumya Bhatt, Weilun Ai, Carmen Ma, Geoffrey A. Talmon, Cyrus Desouza. Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation, Insulin Resistance, and Non-Alcoholic Fatty Liver Disease in Obesity. Biology 2020; 9(11): 346 doi: 10.3390/biology9110346
|
| 136 |
Mohamed Abdalla Salman, Ahmed Abdallah Salman, Mohammad El Sherbiny, Shaimaa Elkholy, Ahmed Youssef, Safa Labib, Mohamed Tag El-Din, Khaled A Monazea, Mohamed Sabry Tourky, Hani Maurice Sabri Mikhail, Karim K Maurice, Ahmed Abdallah, Mohamed Saber Mostafa, Ahmed Mahmoud Hussein, Ahmed Mohammed Abdelsalam, Nesrin Abd Allah, Amr M. Ismaeel Saadawy, Hossam El-Din Shaaban, Mohamed D. Sarhan. Changes of Carotid Intima-Media Thickness After Sleeve Gastrectomy in High Cardiovascular Risk Patients: a Prospective Study. Obesity Surgery 2021; 31(8): 3541 doi: 10.1007/s11695-021-05419-5
|
| 137 |
Anjali Singh, Baby Anjum, Qulsoom Naz, Sana Raza, Rohit A. Sinha, Mohammad Kaleem Ahmad, Abbas Ali Mehdi, Narsingh Verma. Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.88
|
| 138 |
Like Ling, Ruilin Li, Mengqiong Xu, Junjie Zhou, Manli Hu, Xin Zhang, Xiao-Jing Zhang. Species differences of fatty liver diseases: comparisons between human and feline. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(1): E46 doi: 10.1152/ajpendo.00014.2024
|
| 139 |
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
|
| 140 |
Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers. Metabolites 2022; 12(11): 1073 doi: 10.3390/metabo12111073
|
| 141 |
Ming Jiao, Jiaoli Chen, Xiaoling Wang, Wenyu Tao, Yunhua Feng, Huijun Yang, Haiying Yang, Shanshan Zhao, Ying Yang, Yiping Li. Anthropometric and metabolic parameters associated with visceral fat in non-obese type 2 diabetes individuals. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01583-1
|
| 142 |
Ke Pei, Ting Gui, Dongfang Kan, Huichao Feng, Yanqiang Jin, Ying Yang, Qian Zhang, Ziwei Du, Zhibo Gai, Jibiao Wu, Yunlun Li, Kusum Kharbanda. An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4020249
|
| 143 |
Bayan Abdulhafid Aljahdali, Adnan Salem Bajaber, Doha M. Al-Nouri, Abdulrahman Saleh Al-Khalifah, Shaista Arzoo, Abeer Abdullah Alasmari. The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models. Life 2023; 13(6): 1336 doi: 10.3390/life13061336
|
| 144 |
Kyeong-Ju Lee, Seong-Bin Yang, Jae-Hyeon Lee, Bison Seo, Hyung-Sik Won, Jooho Park. Preparation and Therapeutic Evaluation of Engineered Semaglutide and Statin–Lipid Conjugate-Based Nanoparticle. Pharmaceutics 2025; 17(4): 480 doi: 10.3390/pharmaceutics17040480
|
| 145 |
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022; 158(11): 550 doi: 10.1016/j.medcli.2021.12.003
|
| 146 |
Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand. Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis. Medicines 2023; 10(5): 32 doi: 10.3390/medicines10050032
|
| 147 |
Eri Nanizawa, Shun Otsuka, Naoyuki Hatayama, Yuki Tamaki, Yumi Hayashi, Tetsuya Ishikawa, Shuichi Hirai, Munekazu Naito. Short-term high-fat and high-carbohydrate diets increase susceptibility to liver injury by inducing hepatic procoagulant and proinflammatory conditions with different balances. Nutrition 2022; 101: 111710 doi: 10.1016/j.nut.2022.111710
|
| 148 |
Helda Tutunchi, Fatemeh Naeini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Majid Mobasseri, Alireza Ostadrahimi. Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101754 doi: 10.1016/j.clinre.2021.101754
|
| 149 |
Lurao Li, Yun Yi, Xiawen Shu, Jianghui Li, Hui Kang, Ying Chang. The Correlation Between Serum Copper and Non-alcoholic Fatty Liver Disease in American Adults: an Analysis Based on NHANES 2011 to 2016. Biological Trace Element Research 2024; 202(10): 4398 doi: 10.1007/s12011-023-04029-9
|
| 150 |
Chun-Ho Yun, Jing-Rong Jhuang, Meng-Ting Tsou. Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06030-z
|
| 151 |
Shikha Shrivastava, Eric G. Meissner, Emily Funk, Seerat Poonia, Virender Shokeen, Arun Thakur, Bhawna Poonia, Shiv Kumar Sarin, Nirupma Trehanpati, Shyamasundaran Kottilil. Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis. Hepatology International 2016; 10(6): 937 doi: 10.1007/s12072-016-9733-6
|
| 152 |
Yasushi Honda, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Masato Yoneda, Satoru Saito, Yoji Nagashima, Atsushi Nakajima. Protective effect of SGL5213, a potent intestinal sodium–glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice. Journal of Pharmacological Sciences 2021; 147(2): 176 doi: 10.1016/j.jphs.2021.07.002
|
| 153 |
Nicole E. De Long, Eric J. Barry, Christopher Pinelli, Geoffrey A. Wood, Daniel B. Hardy, Katherine M. Morrison, Valerie H. Taylor, Hertzel C. Gerstein, Alison C. Holloway. Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats. Toxicology and Applied Pharmacology 2015; 285(1): 32 doi: 10.1016/j.taap.2015.03.006
|
| 154 |
Yiqing Gu, Shuni Duan, Mingning Ding, Qi Zheng, Guifang Fan, Xiaojiaoyang Li, Yijie Li, Chuanyang Liu, Rong Sun, Runping Liu. Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway. Phytomedicine 2022; 103: 154219 doi: 10.1016/j.phymed.2022.154219
|
| 155 |
Alexandria J. Robbins, Stephen Ritter, Matthew Markese, Mariya E. Skube, Kendall R. McEachron, Melena D. Bellin, Mark J. Stice, Gregory J. Beilman, Robben Schat, Benjamin Spilseth. Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant. American Journal of Roentgenology 2021; 217(1): 100 doi: 10.2214/AJR.20.23303
|
| 156 |
Maria Anastasia Ricci, Stefano De Vuono, Matteo Scavizzi, Alessandra Gentili, Graziana Lupattelli. Facing Morbid Obesity. Angiology 2016; 67(4): 391 doi: 10.1177/0003319715595735
|
| 157 |
Song Lu, Maobin Kuang, Jinjing Yue, Chong Hu, Guotai Sheng, Yang Zou. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01712-z
|
| 158 |
T.I. Yefimenko, M.R. Mykytyuk. Non-alcoholic fatty liver disease: time for changes. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2021; 17(4): 334 doi: 10.22141/2224-0721.17.4.2021.237350
|
| 159 |
Chenyang Zhang, Bin Zhang, Xuelian Zhang, Min Wang, Xiaobo Sun, Guibo Sun. Panax notoginsengSaponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation. Journal of the American Heart Association 2022; 11(4) doi: 10.1161/JAHA.121.023540
|
| 160 |
Iwona Cichon, Weronika Ortmann, Michal Santocki, Malgorzata Opydo-Chanek, Elzbieta Kolaczkowska. Scrutinizing Mechanisms of the ‘Obesity Paradox in Sepsis’: Obesity Is Accompanied by Diminished Formation of Neutrophil Extracellular Traps (NETs) Due to Restricted Neutrophil–Platelet Interactions. Cells 2021; 10(2): 384 doi: 10.3390/cells10020384
|
| 161 |
Xiaowen Bao, Jiaqi Li, Chaoxing Ren, Jingxun Wei, Xuanzhao Lu, Xiaoxuan Wang, Wei Du, Xin Jin, Beiting Ma, Qi Zhang, Bo Ma. Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway. Chemico-Biological Interactions 2022; 365: 110074 doi: 10.1016/j.cbi.2022.110074
|
| 162 |
Ali M Someili, Mostafa Mohrag, Bandar S Rajab, Abdulrahman A Daghreeri, Fawaz M Hakami, Riyadh A Jahlan, Abdulrahman A Otaif, Abdulelah A Otaif, Hussam T Hakami, Bandar F Daghriri, Ameer M Mobarki, Rakan B Almjlad, Mousa Mobarki. Knowledge, Attitudes, and Determinants of Nonalcoholic Fatty Liver Disease Among Adults in Jazan Province: A Cross-Sectional Study. Cureus 2024; doi: 10.7759/cureus.66837
|
| 163 |
Tanishq Kumar, Sarthak Das, V Vinayagamoorthy, Saroj Kumar Tripathy, Archana Malik, Soumi Kundu. Prevalence of nonalcoholic fatty liver disease among overweight and obese children from a teaching institution of Jharkhand: A cross-sectional study. Journal of Family Medicine and Primary Care 2025; 14(4): 1218 doi: 10.4103/jfmpc.jfmpc_1312_24
|
| 164 |
Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Anders Ellekaer Junker, Majken Karoline Jensen, Lise Lotte Gluud. Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2021; 10(3): 404 doi: 10.3390/jcm10030404
|
| 165 |
Francisco J. Amaro-Gahete, Jesús G. Ponce-González, Juan Corral-Pérez, Daniel Velázquez-Díaz, Carl J. Lavie, David Jiménez-Pavón. Effect of a 12-Week Concurrent Training Intervention on Cardiometabolic Health in Obese Men: A Pilot Study. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.630831
|
| 166 |
Botao Zeng, Ruifan Wu, Yushi Chen, Wei Chen, Youhua Liu, Xing Liao, Guanqun Guo, Xinxia Wang. FTO knockout in adipose tissue effectively alleviates hepatic steatosis partially via increasing the secretion of adipocyte-derived IL-6. Gene 2022; 818: 146224 doi: 10.1016/j.gene.2022.146224
|
| 167 |
Qingyuan Song, Roberta M. diFlorio-Alexander, Ryan T. Sieberg, Dennis Dwan, William Boyce, Kyle Stumetz, Sohum D. Patel, Margaret R. Karagas, Todd A. MacKenzie, Saeed Hassanpour. Automated classification of fat-infiltrated axillary lymph nodes on screening mammograms. The British Journal of Radiology 2023; 96(1151) doi: 10.1259/bjr.20220835
|
| 168 |
Tian Su, Yue He, Min Wang, Haiyan Zhou, Yan Huang, Mingsheng Ye, Qi Guo, Ye Xiao, Guangping Cai, Mingyang Zhao, Jianping Wang, Xianghang Luo. Macrophage‐Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis. Advanced Science 2024; 11(42) doi: 10.1002/advs.202406500
|
| 169 |
Lingyan Liu, Yongkun Deng, Lijuan Yang, Miaojiao Wang, Yong Lai. Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis. Journal of Diabetes and its Complications 2025; 39(4): 108998 doi: 10.1016/j.jdiacomp.2025.108998
|
| 170 |
M. de la Torre, J. Buades-Mateu, B. Sangro. Protocolo diagnóstico de la elevación de transaminasas en el embarazo. Medicine - Programa de Formación Médica Continuada Acreditado 2016; 12(10): 575 doi: 10.1016/j.med.2016.05.005
|
| 171 |
Liwei Ji, Xintian Cai, Yang Bai, Tao Li. Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China. International Journal of General Medicine 2021; : 2909 doi: 10.2147/IJGM.S319759
|
| 172 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
|
| 173 |
Anna Thorsø Larsen, Sofie Gydesen, Nina Sonne, Morten Asser Karsdal, Kim Henriksen. The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-020-00678-2
|
| 174 |
Rui Meng, Hui Wang, Zhikang Si, Xuelin Wang, Zekun Zhao, Haipeng Lu, Yizhan Zheng, Jiaqi Chen, Huan Wang, Jiaqi Hu, Ling Xue, Xiaoming Li, Jian Sun, Jianhui Wu. Analysis of factors affecting nonalcoholic fatty liver disease in Chinese steel workers and risk assessment studies. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01886-0
|
| 175 |
ACHILES QUEIROZ MONTEIRO DE REZENDE, MARTINHO ANTÔNIO GESTIC, MURILLO PIMENTEL UTRINI, FELIPE DAVID MENDONÇA CHAIM, HELENA PAES DE ALMEIDA DE SAITO, ELINTON ADAMI CHAIM, FRANCISCO CALLEJAS-NETO, EVERTON CAZZO. Is there a link between non-alcoholic fatty liver disease aspects and pancreatic cancer? Results of a case-matched study. Revista do Colégio Brasileiro de Cirurgiões 2021; 48 doi: 10.1590/0100-6991e-20202913
|
| 176 |
Feyzi GÖKOSMANOĞLU, Kerim GÜZEL, Gülşah BAYÇELEBİ. Bariatrik Cerrahi Olgularında Preoperatif Değerlendirme Sırasında Tespit Edilen Hastalıkların Prevalansı. Sakarya Medical Journal 2020; doi: 10.31832/smj.791837
|
| 177 |
Lin Wu, Yue Wang, Gefu Chi, Bingyu Shen, Ye Tian, Zheng Li, Lu Han, Qiaoling Zhang, Haihua Feng. Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes. Journal of Cellular Physiology 2019; 234(11): 19785 doi: 10.1002/jcp.28578
|
| 178 |
Mallory D. Griffin, Rosalyn D. Abbott. Scientific Principles of Adipose Stem Cells. 2022; : 121 doi: 10.1016/B978-0-12-819376-1.00011-1
|
| 179 |
Justin Bauzon, Judy Jin, Salem Noureldine, Sarah Ziqi Wang, Tim Beck, Gustavo Romero-Velez. Association of Obesity on Rates of Multiglandular Disease in Primary Hyperparathyroidism: A Cohort Study. Journal of Surgical Research 2025; 305: 349 doi: 10.1016/j.jss.2024.12.006
|
| 180 |
Rui Wang, Yuheng Mao, Chunping Yu, Zhenji Rong, Ruyue Wang, Yixin Wang, Linjin Lv, Yang Gao, Zhigang Wang, Hailong Zhang. Research Progress of Natural Products with the Activity of Anti-nonalcoholic Steatohepatitis. Mini-Reviews in Medicinal Chemistry 2024; 24(21): 1894 doi: 10.2174/0113895575306598240503054317
|
| 181 |
M.ª Teófila Vicente-Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/rcmf.150205
|
| 182 |
Exsal M. Albores-Méndez, Humberto Carrasco-Vargas, Samary Alaniz Monreal, Rodolfo David Mayen Quinto, Ernesto Diderot López García, Gabriela Gutierrez Salmean, Karen Medina-Quero, Marco A. Vargas-Hernández, Cesar Vicente Ferreira Batista, Yamilé López-Hernández, Robert Winkler. An intense 60-day weight-loss course leads to an 18 kg body weight reduction and metabolic reprogramming of soldiers with obesity. PeerJ 2024; 12: e17757 doi: 10.7717/peerj.17757
|
| 183 |
Katherine J. P. Schwenger, Maryam Alali, Yasaman Ghorbani, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard. Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease. Obesity Surgery 2023; 33(1): 247 doi: 10.1007/s11695-022-06380-7
|
| 184 |
Guiyuan Jin, Xiaoying Yao, Dong Liu, Juan Zhang, Xiaobei Zhang, Yonghong Yang, Yanzhen Bi, Hui Zhang, Guanjun Dong, Huixin Tang, Shumin Cheng, Feng Hong, Meng Si. Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy. Immunity, Inflammation and Disease 2023; 11(12) doi: 10.1002/iid3.1114
|
| 185 |
Jordan E. Lake, Turner Overton, Susanna Naggie, Mark Sulkowski, Rohit Loomba, David E. Kleiner, Jennifer C. Price, Kara W. Chew, Raymond T. Chung, Kathleen E. Corey. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. Clinical Gastroenterology and Hepatology 2022; 20(2): 256 doi: 10.1016/j.cgh.2020.10.018
|
| 186 |
Rui Hu, Xiaoyue Yang, Xiaoyu He, Guangyao Song. The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-022-01771-2
|
| 187 |
Renuka Suvarna, Mohammed A. Nasir, Weena Stanley, M. Mukhyaprana Prabhu. Anthropometric Indices and Type 2 Diabetes Mellitus as a Risk Factor in Predicting Nonalcoholic Fatty Liver Disease – A Prospective Study in Indian Population. Indian Journal of Community Medicine 2022; 47(3): 386 doi: 10.4103/ijcm.ijcm_1213_21
|
| 188 |
Xiaohui Ma, Lina Chang, Shuo Li, Yian Gu, Jieying Wan, Hequn Sang, Li Ding, Ming Liu, Qing He. Genetic associations of birthweight, childhood, and adult BMI with metabolic dysfunction-associated steatotic liver disease: a Mendelian randomization. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03383-9
|
| 189 |
Kaihao Wang, Anlei Wang, Shaozu Wang, Zhijiang Luo, Yazhao Gong, Xiaoliang Hao, Guanglei Yang, Shuqing Xu. The best anthropometric indices to predict colon cancer. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03832-z
|
| 190 |
Maria Mukhtar, Mohammed J Alzubaidee, Raga Sruthi Dwarampudi, Sheena Mathew, Sumahitha Bichenapally, Vahe Khachatryan, Asmaa Muazzam, Chandani Hamal, Lakshmi Sai Deepak Reddy Velugoti, Godfrey Tabowei, Greeshma N Gaddipati, Safeera Khan. Role of Non-pharmacological Interventions and Weight Loss in the Management of Gastroesophageal Reflux Disease in Obese Individuals: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.28637
|
| 191 |
Jean-Jacques Houben, Yvon Carpentier, Genevieve Paulissen, Georges Van Snick, Antoine Soetewey. Impact of a Food Rebalancing Program Associated with Plant-Derived Food Supplements on the Biometric, Behavioral, and Biological Parameters of Obese Subjects. Nutrients 2023; 15(22): 4780 doi: 10.3390/nu15224780
|
| 192 |
Yu Jin, Qiuyan Liu, Yuqin Wang, Bing Wang, Jing An, Qimeng Chen, Tao Wang, Jing Shang. Propylthiouracil Induced Rat Model Reflects Heterogeneity Observed in Clinically Non-Obese Subjects with Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(19): 10764 doi: 10.3390/ijms251910764
|
| 193 |
Anjana Reddy, Paul Della Gatta, Shaun Mason, Amanda J. Nicoll, Marno Ryan, Catherine Itsiopoulos, Gavin Abbott, Nathan A. Johnson, Siddharth Sood, Stuart K. Roberts, Elena S. George, Audrey C. Tierney. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: The MEDINA randomized controlled trial. Nutrition Research 2023; 119: 98 doi: 10.1016/j.nutres.2023.09.005
|
| 194 |
Gi Cheol Park, Soo-Young Bang, Ji Min Kim, Sung-Chan Shin, Yong-il Cheon, Kwang Min Kim, Hanaro Park, Eui-Suk Sung, Minhyung Lee, Jin-Choon Lee, Byung-Joo Lee. Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice. Antioxidants 2024; 13(11): 1336 doi: 10.3390/antiox13111336
|
| 195 |
Juntao Yuan, Zhuoran Yu, Junling Gao, Kai Luo, Xiyue Shen, Bingqing Cui, Zhongbing Lu. Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation. Redox Biology 2022; 49: 102224 doi: 10.1016/j.redox.2021.102224
|
| 196 |
Chen Chen, Wenkang Zhang, Gaoliang Yan, Chengchun Tang. Identifying metabolic dysfunction-associated steatotic liver disease in patients with hypertension and pre-hypertension: An interpretable machine learning approach. DIGITAL HEALTH 2024; 10 doi: 10.1177/20552076241233135
|
| 197 |
Hui Yu, Xiangzhou Yi, Xia Gao, Jun Ji, Zhongyuan Liu, Guanghua Xia, Chuan Li, Xueying Zhang, Xuanri Shen. Tilapia-Head Chondroitin Sulfate Protects against Nonalcoholic Fatty Liver Disease via Modulating the Gut–Liver Axis in High-Fat-Diet-Fed C57BL/6 Mice. Foods 2022; 11(7): 922 doi: 10.3390/foods11070922
|
| 198 |
G. Conti, L. Calderan, L.A. Quintero Sierra, A. Conti, R. Ossanna, F. Boschi, P. Marzola, F. Ferrarini, M. Governa, P.M.-J. Lievens, A. Sbarbati. Tumor and peritumoral adipose tissue crosstalk: De-differentiated adipocytes influence spread of colon carcinoma cells. Tissue and Cell 2023; 80: 101990 doi: 10.1016/j.tice.2022.101990
|
| 199 |
Hanchen Ma, Wenjie Zhang, Zheng Zhao, Shuaichen Jin, Linchuan Li, Ruizhao Zong, Wuyang Li, Ziwei Zhang, Shichang Cui, Yunmiao Pan, Jiankang Zhu, Guangyong Zhang. Association between triglyceride-glucose related indices and at-risk NASH in U.S. adults with NAFLD: results from NHANES 2017-2020. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1604991
|
| 200 |
Yalçın Burak Kara, Yahya Ozel. Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy. Cureus 2024; doi: 10.7759/cureus.69717
|
| 201 |
Katrin Druschky, Sermin Toto, Stefan Bleich, Jessica Baumgärtner, Rolf R. Engel, Renate Grohmann, Hannah B. Maier, Alexandra Neyazi, Yannick J. Rudolph, Eckart Rüther, Harald Schwörer, Johanna Seifert, Susanne Stübner, Detlef Degner. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study. The World Journal of Biological Psychiatry 2021; 22(5): 373 doi: 10.1080/15622975.2020.1819565
|
| 202 |
Xian Sun, Shuoqiu Zhang, Xi Zhou. A causal association between obesity and constipation: a two-sample bidirectional Mendelian randomization study and meta-analysis. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1430280
|
| 203 |
Eunju Kim. Effects of Natural Alternative Sweeteners on Metabolic Diseases. Clinical Nutrition Research 2023; 12(3): 229 doi: 10.7762/cnr.2023.12.3.229
|
| 204 |
Irislene Costa Pereira, Álina Mara Carvalho Pedrosa-Santos, Jorddam Almondes Martins, Athanara Alves de Sousa, Taline Alves Nobre, Lucillia Rabelo de Oliveira Torres, Felipe Cavalcanti Carneiro da Silva, Juliana Soares Severo, João Marcelo de Castro e Sousa, Francisco Leonardo Torres-Leal. Bromelain and liver health: A comprehensive systematic review of preclinical studies. Clinical Nutrition ESPEN 2025; 66: 437 doi: 10.1016/j.clnesp.2025.02.001
|
| 205 |
Thamires Barros Tavares, Izabelle Barcellos Santos, Graziele Freitas de Bem, Dayane Teixeira Ognibene, Ana Paula Machado da Rocha, Roberto Soares de Moura, Angela de Castro Resende, Julio Beltrame Daleprane, Cristiane Aguiar da Costa. Therapeutic effects of açaí seed extract on hepatic steatosis in high-fat diet-induced obesity in male mice: a comparative effect with rosuvastatin. Journal of Pharmacy and Pharmacology 2020; 72(12): 1921 doi: 10.1111/jphp.13356
|
| 206 |
Yuanfeng Lan, Ran Song, Duiping Feng, Junqi He. Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-90744-3
|
| 207 |
Ryutaro Kuraji, Satoshi Sekino, Yvonne Kapila, Yukihiro Numabe. Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis. Periodontology 2000 2021; 87(1): 204 doi: 10.1111/prd.12387
|
| 208 |
Yuanjie Pang, Christiana Kartsonaki, Jun Lv, Iona Y Millwood, Zammy Fairhurst-Hunter, Iain Turnbull, Fiona Bragg, Michael R Hill, Canqing Yu, Yu Guo, Yiping Chen, Ling Yang, Robert Clarke, Robin G Walters, Ming Wu, Junshi Chen, Liming Li, Zhengming Chen, Michael V Holmes. Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study. The American Journal of Clinical Nutrition 2022; 115(3): 799 doi: 10.1093/ajcn/nqab392
|
| 209 |
M.ª Teófila Vicente Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/150205
|
| 210 |
P. F. Peppi, G. A. Lira, L. R. S. Campos, C. R. Santos, E. M. M. Lima, A. R. C. Barreto-Vianna. Liver under attack: impacts of high-fat diet on murine model. Brazilian Journal of Biology 2024; 84 doi: 10.1590/1519-6984.284045
|
| 211 |
Shuhua Shen, Kungen Wang, Yihui Zhi, Yue Dong. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways. Pharmaceutical Biology 2022; 60(1): 1949 doi: 10.1080/13880209.2022.2126503
|
| 212 |
Jiabao Liao, Mengqiu Shao, Ze Zhou, Si Wang, You Lv, Yanming Lu, Fang Yao, Wenting Li, Ling Yang. Correlation of organelle interactions in the development of non-alcoholic fatty liver disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1567743
|
| 213 |
Xingyu Xie, Yingyi Liao, Zixin Lin, Huijuan Luo, Guilan Wei, Ning Huang, Yucui Li, Jiannan Chen, Ziren Su, Xiuting Yu, Liping Chen, Yuhong Liu. Patchouli alcohol alleviates metabolic dysfunction-associated steatohepatitis via inhibiting mitochondria-associated endoplasmic reticulum membrane disruption-induced hepatic steatosis and inflammation in rats. International Immunopharmacology 2024; 138: 112634 doi: 10.1016/j.intimp.2024.112634
|
| 214 |
Yongxin Wang, Chang Fu, Hengwei Jin, Yibo Yang, Xiaocong Li, Kai Liu. Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey. Frontiers in Endocrinology 2025; 15 doi: 10.3389/fendo.2024.1468228
|
| 215 |
Ling Ruan, Guanghua Wang, Zhen Qing Lv, Shoubang Li, Qin Liu, Yiling Ren, Quancheng Zhang, Xianli Lv, Rongping Wu, Zhan Ji. The effect of varied exercise intensity on antioxidant function, aortic endothelial function, and serum lipids in rats with non-alcoholic fatty liver disease.. Investigación Clínica 2022; 63(4): 327 doi: 10.54817/IC.v63n4a01
|
| 216 |
Lei Yang, Shaoning Jiang. Adipose Tissue-Derived Extracellular Vesicle MicroRNAs: Diagnostic Biomarkers for the Pathophysiology Associated with Obesity. Precision Chemistry 2025; doi: 10.1021/prechem.5c00007
|
| 217 |
Lu-Jie Liu, Yu-Rong Kang, Yan-Feng Xiao. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity. World Journal of Pediatrics 2021; 17(4): 394 doi: 10.1007/s12519-021-00444-x
|
| 218 |
Qiaorui Wen, Tanxin Liu, Yuelin Yu, Yunjing Zhang, Yingzi Yang, Rongshou Zheng, Liming Li, Ru Chen, Shengfeng Wang. Self-Reported Primary Cooking Fuels Use and Risk of Chronic Digestive Diseases: A Prospective Cohort Study of 0.5 Million Chinese Adults. Environmental Health Perspectives 2023; 131(4) doi: 10.1289/EHP10486
|
| 219 |
Bita Eslami, Najmeh Aletaha, Arezoo Maleki-Hajiagha, Mahdi Sepidarkish, Ashraf Moini. Evaluation of the predictive value of body mass index (BMI), waist circumference, and visceral fat to differentiate non-alcoholic fatty liver (NAFLD) in women with polycystic ovary syndrome. Journal of Research in Medical Sciences 2022; 27(1): 37 doi: 10.4103/jrms.JRMS_292_20
|
| 220 |
Yu-Ho Chang, Pei-Ni Lee, Cheng-Hsu Chen, Hsin-Yi Yang, Chi-Hao Wu, Jia-Yau Doong, Wan-Ju Yeh. Substituting animal protein with black soymilk reduces advanced glycation end product level and improves gut microbiota composition in obese prediabetic individuals: a randomized crossover intervention trial. Food & Function 2025; 16(1): 195 doi: 10.1039/D4FO04717F
|
| 221 |
Jiejun Shi, Jianhua Chen, Zeqin Zhang, Guoqing Qian. Multi-dimensional comparison of abdominal obesity indices and insulin resistance indicators for assessing NAFLD. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-19657-6
|
| 222 |
Fàtima Sabench, Laia Bertran, Margarita Vives, Marta París, Carmen Aguilar, Salomé Martínez, Jessica Binetti, Monica Real, Alja Alibalic, Cristóbal Richart, Daniel del Castillo, Teresa Auguet. NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity. Obesity Surgery 2022; 32(10): 3313 doi: 10.1007/s11695-022-06175-w
|
| 223 |
AnaPaula de A. Boleti, PedroHenrique de O. Cardoso, BrenoEmanuel F. Frihling, PatríciaSouza e Silva, LuizFilipe R. N. de Moraes, Ludovico Migliolo. Adipose tissue, systematic inflammation, and neurodegenerative diseases. Neural Regeneration Research 2023; 18(1): 38 doi: 10.4103/1673-5374.343891
|
| 224 |
Hongzhan Tian, Kexin Zhang, Zongguang Hui, Fangbing Ren, Yanhui Ma, Fang Han, Xiaodong Sun, Chengxia Kan, Ningning Hou. Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019. Clinics and Research in Hepatology and Gastroenterology 2023; 47(1): 102068 doi: 10.1016/j.clinre.2022.102068
|
| 225 |
Wei-ning Jiang, Dan Li, Tao Jiang, Jiao Guo, Yan-fen Chen, Jie Wang, Yun Zhou, Chao-yan Yang, Chun-ping Tang. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Chinese Journal of Integrative Medicine 2018; 24(2): 125 doi: 10.1007/s11655-016-2252-4
|
| 226 |
Kento IMAJO, Yasushi HONDA, Masato YONEDA, Satoru SAITO, Atsushi NAKAJIMA. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. Choonpa Igaku 2022; 49(5): 411 doi: 10.3179/jjmu.JJMU.R.203
|
| 227 |
Koushal Sattaru, Mansi Thipani Madhu, Janmejay Kumar Singh, Venkataramana Kandi, Aastha Gupta, Jayashankar CA, Ojas Balaji, Nidhishri Sridhar, Vennela Talla. A Comprehensive Review of the Effects of Diabetes Mellitus on the Gastrointestinal System. Cureus 2025; doi: 10.7759/cureus.77845
|
| 228 |
Yuying Ma, Xuecui Yin, Zhenzhen Qin, Xiaofei Ke, Yang Mi, Pengyuan Zheng, Youcai Tang. Role of Plin5 Deficiency in Progression of Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Journal of Comparative Pathology 2021; 189: 88 doi: 10.1016/j.jcpa.2021.10.002
|
| 229 |
Nader Lessan. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 161 doi: 10.1002/9781118924938.ch18
|
| 230 |
Alice P. Sowton, Lorenz M. W. Holzner, Fynn N. Krause, Ruby Baxter, Gabriele Mocciaro, Dominika K. Krzyzanska, Magdalena Minnion, Katie A. O’Brien, Matthew C. Harrop, Paula M. Darwin, Benjamin D. Thackray, Michele Vacca, Martin Feelisch, Julian L. Griffin, Andrew J. Murray. Chronic inorganic nitrate supplementation does not improve metabolic health and worsens disease progression in mice with diet-induced obesity. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(1): E69 doi: 10.1152/ajpendo.00256.2024
|